Legis Daily

FLAT Prices Act

USA116th CongressHR-1188| House 
| Updated: 2/14/2019
Jared F. Golden

Jared F. Golden

Democratic Representative

Maine

Cosponsors (7)
Gilbert Ray Cisneros (Democratic)Max Rose (Democratic)Abby Finkenauer (Democratic)Sean Casten (Democratic)Elissa Slotkin (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 6, 2019

Latest Companion Bill Action

S 116-366
Introduced in Senate
Feb 13, 2019
Introduced in House
Feb 13, 2019
Referred to the House Committee on Energy and Commerce.
Feb 14, 2019
Referred to the Subcommittee on Health.
  • February 6, 2019

    Latest Companion Bill Action

    S 116-366
    Introduced in Senate


  • February 13, 2019
    Introduced in House


  • February 13, 2019
    Referred to the House Committee on Energy and Commerce.


  • February 14, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • S 116-366: FLAT Prices Act
Business recordsDrug safety, medical device, and laboratory regulationGovernment information and archivesHealth care costs and insuranceInflation and pricesLicensing and registrationsPrescription drugs

FLAT Prices Act

USA116th CongressHR-1188| House 
| Updated: 2/14/2019
Forcing Limits on Abusive and Tumultuous Prices or the FLAT Prices Act This bill directs the Food and Drug Administration to reduce the market exclusivity of an approved prescription drug if the drug manufacturer increases the drug's price by more than a specified percentage. This reduction may be waived under specified circumstances.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 6, 2019

Latest Companion Bill Action

S 116-366
Introduced in Senate
Feb 13, 2019
Introduced in House
Feb 13, 2019
Referred to the House Committee on Energy and Commerce.
Feb 14, 2019
Referred to the Subcommittee on Health.
  • February 6, 2019

    Latest Companion Bill Action

    S 116-366
    Introduced in Senate


  • February 13, 2019
    Introduced in House


  • February 13, 2019
    Referred to the House Committee on Energy and Commerce.


  • February 14, 2019
    Referred to the Subcommittee on Health.
Jared F. Golden

Jared F. Golden

Democratic Representative

Maine

Cosponsors (7)
Gilbert Ray Cisneros (Democratic)Max Rose (Democratic)Abby Finkenauer (Democratic)Sean Casten (Democratic)Elissa Slotkin (Democratic)Lloyd Doggett (Democratic)Chellie Pingree (Democratic)

Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • S 116-366: FLAT Prices Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business recordsDrug safety, medical device, and laboratory regulationGovernment information and archivesHealth care costs and insuranceInflation and pricesLicensing and registrationsPrescription drugs